AnazaoHealth Corporation, Las Vegas

FDA 503B registration status

FDA 503B list ✓ (current 2026-08-10)

AnazaoHealth Corporation, Las Vegas appears on FDA's registered outsourcing facilities list, parsed from Veritura's capture of that list (FDA list current as of 2026-08-10, captured 2026-08-16). Registration status can change between captures; the FDA page is the authoritative current source.

On our captures

On FDA's list since we began tracking captures on 2026-07-11 (tracking began 2026-07-10; we make no claim about FDA's list before our first capture). Last confirmed on our 2026-08-11 capture (FDA list current as of 2026-08-10).

Dates are Veritura's own capture dates of FDA's public list, shown next to FDA's list-current date wherever we have it. Public-record posture, not a determination.

FDA enforcement timeline

3 dated enforcement records matched this firm name in openFDA when this check last completed.

• 2023-11-22 · drug · Class II · Terminated
  Presence of Particulate Matter.
• 2023-11-22 · drug · Class II · Terminated
  Presence of Particulate Matter.
• 2015-01-26 · drug · Class II · Terminated
  Good Manufacturing Practices Deviations: The product has an active pharmaceutical ingredient from an unapproved source.

Source: openFDA enforcement records (drug/device/food, updated weekly), checked 2026-08-19. Dated public records matching this firm name; similar firm names collide in public records, so confirm the firm identity against the source records before relying. Public-record posture, not a determination.

Live FDA enforcement screen

3 enforcement record matches on this firm name in openFDA when this screen last ran. Review the underlying public records and confirm the firm identity before relying on this signal.

0 FDA compliance action records matched this name.

Source: openFDA enforcement records and FDA compliance dashboards, refreshed at most every 6 hours. A count here documents what public sources returned for this name (searched: AnazaoHealth Corporation, Las Vegas); it is not a Veritura determination about the facility.

Reported products

35 distinct products as reported to FDA in 503B product reports (data vintage: reporting periods 2026-1, 2025-2); 20 shown.

• Anastrozole; Testosterone · 1 mg/1 mg; 1 mg/1 mg · pellet · reported period 2026-1
• Arginine Hydrochloride; Proline; Glutamine; Lysine Hydrochloride · 50 mg/1 mL; 25 mg/1 mL; 15 mg/1 mL; 15 mg/1 mL · injection · reported period 2026-1
• Ascorbic Acid · 500 mg/1 mL · injection · reported period 2026-1
• Choline Chloride; Methionine; Inositol; Cyanocobalamin · 50 mg/1 mL; 25 mg/1 mL; 50 mg/1 mL; 1 mg/1 mL · injection · reported period 2026-1
• Estradiol · 12.5 mg/12.5 mg · pellet · reported period 2026-1
• Estradiol · 15 mg/15 mg · pellet · reported period 2026-1
• Estradiol · 25 mg/25 mg · pellet · reported period 2026-1
• Estradiol · 10 mg/10 mg · pellet · reported period 2026-1
• Estradiol · 6 mg/6 mg · pellet · reported period 2026-1
• Estradiol · 20 mg/20 mg · pellet · reported period 2026-1
• Glutathione · 200 mg/1 mL · injection · reported period 2026-1
• Lysine Hydrochloride · 100 mg/1 mL · injection · reported period 2026-1
• Lysine Hydrochloride; Arginine Hydrochloride; Proline; Glutamine · 15 mg/1 mL; 50 mg/1 mL; 25 mg/1 mL; 15 mg/1 mL · injection · reported period 2026-1
• Methionine; Inositol; Choline Chloride · 25 mg/1 mL; 50 mg/1 mL; 50 mg/1 mL · injection · reported period 2026-1
• Methylcobalamin · 5000 mg/1 mL · injection · reported period 2026-1
• Methylcobalamin · 10000 mg/1 mL · injection · reported period 2026-1
• Nandrolone Decanoate · 200 mg/1 mL · injection · reported period 2026-1
• Nicotinamide-Adenine Dinucleotide Phosphate, Reduced · 100 mg/1 mL · injection · reported period 2026-1
• Nicotinamide-Adenine Dinucleotide Phosphate, Reduced · 125 mg/1 mL · injection · reported period 2026-1
• Proline · 100 mg/1 mL · injection · reported period 2026-1

Source: FDA outsourcing facility product reports (FD&C 503B(b)(2)). Retrospective by design: a row means the facility reported compounding this product to FDA in the named period, never that it currently compounds, can supply, or is endorsed for it. Public-record posture, not a determination.

Watch this facility

Get an email if this facility's FDA list status or enforcement record changes between our captures. Public-record change notices only; every email carries a one-click unsubscribe link.

Is this your facility?

Claim this profile to keep it accurate and attach your own documentation through Veritura. Every claim is verified by hand before anything changes.